These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 28098861)
1. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53. Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861 [TBL] [Abstract][Full Text] [Related]
2. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related]
3. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP. Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208 [TBL] [Abstract][Full Text] [Related]
4. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation. Zhao F; Huang W; Ousman T; Zhang B; Han Y; Clotaire DZ; Wang C; Chang H; Luo H; Ren X; Lei M PLoS One; 2013; 8(11):e80784. PubMed ID: 24244715 [TBL] [Abstract][Full Text] [Related]
5. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells. Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159 [TBL] [Abstract][Full Text] [Related]
6. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982 [TBL] [Abstract][Full Text] [Related]
7. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21. Li X; Zang A; Jia Y; Zhang J; Fan W; Feng J; Duan M; Zhang L; Huo R; Jiao J; Zhu X Mol Med Rep; 2016 Mar; 13(3):2763-8. PubMed ID: 26847601 [TBL] [Abstract][Full Text] [Related]
8. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170 [TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218. Yao C; Li H; Zhang W Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799 [TBL] [Abstract][Full Text] [Related]
10. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430 [TBL] [Abstract][Full Text] [Related]
11. The α-iso-cubebenol compound isolated from Schisandra chinensis induces p53-independent pathway-mediated apoptosis in hepatocellular carcinoma cells. Kim JE; Kim SG; Goo JS; Park DJ; Lee YJ; Hwang IS; Lee HR; Choi SI; Lee YJ; Oh CH; Choi YW; Hwang DY Oncol Rep; 2012 Sep; 28(3):1103-9. PubMed ID: 22736046 [TBL] [Abstract][Full Text] [Related]
12. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway. Zhao X; Zhang Q; Chen L Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934 [TBL] [Abstract][Full Text] [Related]
13. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells. Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138 [TBL] [Abstract][Full Text] [Related]
14. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242 [TBL] [Abstract][Full Text] [Related]
15. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells. Wan CK; Wang C; Cheung HY; Yang M; Fong WF Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721 [TBL] [Abstract][Full Text] [Related]
16. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines. Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422 [TBL] [Abstract][Full Text] [Related]
17. Triptolide induces apoptosis through extrinsic and intrinsic pathways in human osteosarcoma U2OS cells. Kwon HY; Kim KS; An HK; Moon HI; Kim HJ; Lee YC Indian J Biochem Biophys; 2013 Dec; 50(6):485-91. PubMed ID: 24772972 [TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells. Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Biomed Pharmacother; 2016 Oct; 83():22-32. PubMed ID: 27470546 [TBL] [Abstract][Full Text] [Related]
19. [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism]. Deng J; Jin J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):434-9. PubMed ID: 15972136 [TBL] [Abstract][Full Text] [Related]
20. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]